Dr Martin Rothman joins Sofinnova Partners

Life Science-focused European venture capital firm, Sofinnova Partners, has appointed Dr Martin Rothman as venture partner.

Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. There, he will focus on helping the team identify and evaluate “promising” medical device companies.

His new position at the firm will also see him take on a mentor role, as he will guide entrepreneurs and physicians launching clinical innovations.

Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.

“We share a common vision of entrepreneurship and a passion for bringing innovative therapies to patients and the medical community.”

Until recently, Rothman was vice president of medical affairs for coronary, structural heart and renal denervation for Medtronic, where he held that position since 2010.

Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners, said: “Martin is an exceptional physician and repeat entrepreneur.

“His experience ideally complements our team and represents a key asset for Sofinnova Partners at a time when our activity is growing.”